Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 1, 2006, Pages 382-384

  Borriello, Giorgia ^a   Richards, Lee ^a   Ehrlich, Garth D ^b   Stewart, Philip S ^a  

^a MONTANA STATE UNIVERSITY   (United States)

^b ALLEGHENY SINGER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CIPROFLOXACIN; NITRATE; TOBRAMYCIN;

AEROBIC CELL CULTURE; ANAEROBIC CELL CULTURE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BIOFILM; CELL COUNT; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANAEROBIOSIS; ANTI-BACTERIAL AGENTS; ARGININE; BIOFILMS; DRUG SYNERGISM; NITRATES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOBRAMYCIN;

EID: 29944446754     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.1.382-384.2006     Document Type: Article

References (17)

1. Borriello, G., E. Werner, F. Roe, A. M. Kim, G. D. Ehrlich, and P. S. Stewart. 2004. Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms. Antimicrob. Agents Chemother. 48:2659-2664.
2. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
3. Cunin, R., N. Glansdorff, A. Piérard, and V. Stalon. 1986. Biosynthesis and metabolism of arginine in bacteria. Microbiol. Rev. 50:314-352.
4. Dietzsch, H.-J., B. Gottschalk, K. Heyne, W. Leupold, and P. Wunderlich. 1975. Cystic fibrosis: comparison of two mucolytic drugs for inhalation treatment (acetylcysteine and arginine hydrochloride). Pediatrics 55:96-100.
5. Drenkard, E., and F. M. Ausubel. 2002. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature 416:740-743.
6. Grasemann, H., S. S. Gartig, H. G. Wiesemann, H. Teschler, N. Konietzko, and F. Ratjen. 1999. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome. Eur. Respir. J. 13:114-118.
7. Mah, T. F., B. Pitts, B. Pellock, G. C. Walker, P. S. Stewart, and G. A. O'Toole. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310.
8. Solomons, C. C., E. K. Cotton, R. Dubois, and M. Pinney. 1971. The use of buffered L-arginine in the treatment of cystic fibrosis. Pediatrics 47:384-390.
9. Spoering, A. L., and K. Lewis. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183:6746-6751.
10. Vander Wauven, C., A. Piérard, M. Kley-Raymann, and D. Haas. 1984. Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J. Bacteriol. 160:928-934.
11. Walters, M. C., III, F. Roe, A. Bugnicourt, M. J. Franklin, and P. S. Stewart. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47:317-323.
12. Werner, E., F. Roe, A. Bugnicourt, M. J. Franklin, A. Heydorn, S. Molin, B. Pitts, and P. S. Stewart. 2004. Stratified growth in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 70:6188-6196.
13. Worlitzsch, D., R. Tarran, M. Ulrich, U. Schwab, A. Cekici, K. C. Meyer, P. Birrer, G. Bellon, J. Berger, T. Weiss, K. Botzenhart, J. R. Yankaskas, S. Randell, R. C. Boucher, and G. Döring. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Investig. 109:317-325.
14. Xu, K. D., G. A. McFeters, and P. S. Stewart. 2000. Biofilm resistance to antimicrobial agents. Microbiology 146:547-549.
15. Xu, K. D., P. S. Stewart, F. Xia, C.-T. Huang, and G. A. McFeters. 1998. Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability. Appl. Environ. Microbiol. 64:4035-4039.
16. Yoon, S. S., R. F. Hennigan, G. M. Hilliard, U. A. Ochsner, K. Parvatiyar, M. C. Kamani, H. L. Allen, T. R. DeKievit, P. R. Gardner, U. Schwab, J. J. Rowe, B. H. Iglewski, T. R. McDermott, R. P. Mason, D. J. Wozniak, R. E. W. Hancock, M. R. Parsek, T. L. Noah, R. C. Boucher, and D. J. Hassett. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603.
17. Zheng, Z., and P. S. Stewart. 2004. Growth limitation of Staphylococcus epidermidis in biofilms contributes to rifampin tolerance. Biofilms 1:31-35.